INMED PHARMACEUTICALS INC (INM) Stock Balance Sheet
NASDAQ:INM • CA4576377002
Current stock price
0.6558 USD
-0.03 (-3.71%)
At close:
0.6325 USD
-0.02 (-3.55%)
After Hours:
| MRQ (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.95M | 11.08M | 6.57M | 8.91M | 6.18M | |||
| Marketable Securities | 42.70K | 43.40K | 43.10K | 40.00K | 40.00K | |||
| Receivables | 183.00K | 465.10K | 352.80K | 260.00K | 90.00K | |||
| Inventories | 947.90K | 961.20K | 1.24M | 1.62M | 2.49M | |||
| Other Current Assets | 660.30K | 321.80K | 477.80K | 500.00K | 800.00K | |||
| Total Current Assets | 8.79M | 12.87M | 8.69M | 11.33M | 9.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 764.30K | 992.20K | 1.25M | 720.00K | 900.00K | |||
| Intangibles | 1.54M | 1.62M | 1.78M | 1.95M | 2.11M | |||
| Other Non-Current Assets | 100.00K | 100.00K | 100.00K | 100.00K | 180.00K | |||
| Total Non-Current Assets | 2.40M | 2.71M | 3.13M | 2.78M | 3.19M | |||
| TOTAL ASSETS | 11.19M | 15.58M | 11.82M | 14.11M | 12.79M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 1.11M | 1.47M | 1.30M | 1.44M | 1.65M | |||
| Accounts Payable | 166.80K | 370.10K | 626.20K | 540.00K | 1.17M | |||
| Other Current Liabilities | 207.40K | 700.00 | 41.00K | 20.00K | 500.00K | |||
| Total Current Liabilities | 1.48M | 1.84M | 1.97M | 2.00M | 3.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 123.80K | 305.80K | 644.90K | 20.00K | 390.00K | |||
| Total Non-Current Liabilities | 123.80K | 305.80K | 644.90K | 20.00K | 390.00K | |||
| TOTAL LIABILITIES | 1.60M | 2.15M | 2.62M | 2.02M | 3.71M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -120.99M | -117.24M | -109.08M | -101.40M | -93.45M | |||
| Additional Paid In Capital | 38.41M | 39.32M | 35.37M | 35.74M | 31.68M | |||
| Common Shares | 92.05M | 91.22M | 82.78M | 77.62M | 70.72M | |||
| Other Shareholders' Equity | 128.60K | 128.60K | 128.60K | 130.00K | 130.00K | |||
| Shares Outstanding | 2.80M | 2.00M | 446.00K | 3.33M | 650.00K | |||
| Tangible Book Value per Share | 2.87 | 5.90 | 16.65 | 3.04 | 10.72 | |||
| Total Shareholders' Equity | 9.59M | 13.43M | 9.21M | 12.09M | 9.08M | |||
| TOTAL LIABILITIES AND EQUITY | 11.19M | 15.58M | 11.82M | 14.11M | 12.79M | |||
| Statistics | ||||||||
| Current Ratio | 5.94 | 6.99 | 4.41 | 5.67 | 2.89 | |||
| Return On Assets (ROA) | -68.48% | -52.39% | -64.92% | -56.34% | -145.43% | |||
| Return On Equity (ROE) | -79.94% | -60.75% | -83.38% | -65.76% | -204.85% | |||
All data in USD , ROIC based on taxRate of 0.21